NO20002450L - Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type - Google Patents

Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type

Info

Publication number
NO20002450L
NO20002450L NO20002450A NO20002450A NO20002450L NO 20002450 L NO20002450 L NO 20002450L NO 20002450 A NO20002450 A NO 20002450A NO 20002450 A NO20002450 A NO 20002450A NO 20002450 L NO20002450 L NO 20002450L
Authority
NO
Norway
Prior art keywords
tetrahydropyridines
alzheimer
treatment
composition
type
Prior art date
Application number
NO20002450A
Other languages
Norwegian (no)
Other versions
NO20002450D0 (en
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/en
Priority claimed from FR9714322A external-priority patent/FR2771007B1/en
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20002450D0 publication Critical patent/NO20002450D0/en
Publication of NO20002450L publication Critical patent/NO20002450L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002450A 1997-11-14 2000-05-11 Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type NO20002450L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
PCT/FR1998/002384 WO1999025363A1 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia

Publications (2)

Publication Number Publication Date
NO20002450D0 NO20002450D0 (en) 2000-05-11
NO20002450L true NO20002450L (en) 2000-07-14

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002450A NO20002450L (en) 1997-11-14 2000-05-11 Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type

Country Status (27)

Country Link
EP (1) EP1030671A1 (en)
JP (1) JP2001523642A (en)
KR (1) KR100599350B1 (en)
CN (1) CN1243540C (en)
AU (1) AU743228B2 (en)
BG (1) BG64819B1 (en)
BR (1) BR9814035A (en)
CA (1) CA2309966A1 (en)
CO (1) CO4980891A1 (en)
DZ (1) DZ2649A1 (en)
EA (1) EA003255B1 (en)
EE (1) EE04235B1 (en)
HU (1) HUP0100098A3 (en)
ID (1) ID24933A (en)
IL (2) IL136122A0 (en)
IS (1) IS5482A (en)
MY (1) MY120461A (en)
NO (1) NO20002450L (en)
NZ (1) NZ504420A (en)
OA (1) OA11464A (en)
PL (1) PL194597B1 (en)
SA (1) SA98190747B1 (en)
SK (1) SK286040B6 (en)
TR (1) TR200001262T2 (en)
TW (1) TW585766B (en)
UY (1) UY25247A1 (en)
WO (1) WO1999025363A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100935615B1 (en) * 2002-06-14 2010-01-07 토야마 케미칼 컴퍼니 리미티드 Pharmaceutical composition to improve brain function and method for improving brain function
DK1529116T3 (en) * 2002-08-07 2009-11-09 Novartis Ag Method for predicting response to rivastigmine treatment based on the ApoE genotype in dementia patients
CN1520818A (en) * 2003-02-09 2004-08-18 ɽ����Ҷ��Ȼҩ���о��������޹�˾ Cholinesterase inhibitor pharmaceutical composition for treating senile dementia
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2015116923A1 (en) 2014-01-31 2015-08-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
ES3063712T3 (en) * 2017-05-15 2026-04-20 Cognition Therapeutics Inc Compositions for treating neurodegenerative diseases
WO2019182319A1 (en) * 2018-03-20 2019-09-26 (주)인벤티지랩 Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method
KR102224917B1 (en) 2018-03-20 2021-03-09 (주)인벤티지랩 Production methods of preventing or treating cognitive impairment-related disease and preventing or treating cognitive impairment-related disease producing thereto
CN109265391B (en) * 2018-11-13 2021-11-19 枣庄学院 Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (en) * 1990-05-22 1994-11-10 Sanofi Sa USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CA2213000A1 (en) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
FR2736053B1 (en) * 1995-06-28 1997-09-19 Sanofi Sa NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

Also Published As

Publication number Publication date
PL194597B1 (en) 2007-06-29
TR200001262T2 (en) 2001-01-22
MY120461A (en) 2005-10-31
SA98190747B1 (en) 2006-11-04
BG104428A (en) 2001-08-31
IS5482A (en) 2000-05-09
HUP0100098A3 (en) 2001-12-28
IL136122A (en) 2006-07-05
OA11464A (en) 2003-11-18
DZ2649A1 (en) 2004-12-28
EA003255B1 (en) 2003-02-27
UY25247A1 (en) 2001-05-31
EA200000412A1 (en) 2000-12-25
NZ504420A (en) 2003-08-29
SK286040B6 (en) 2008-01-07
PL340500A1 (en) 2001-02-12
AU1160999A (en) 1999-06-07
AU743228B2 (en) 2002-01-24
EP1030671A1 (en) 2000-08-30
BG64819B1 (en) 2006-05-31
EE04235B1 (en) 2004-02-16
IL136122A0 (en) 2001-05-20
CA2309966A1 (en) 1999-05-27
CO4980891A1 (en) 2000-11-27
NO20002450D0 (en) 2000-05-11
TW585766B (en) 2004-05-01
BR9814035A (en) 2000-09-26
WO1999025363A1 (en) 1999-05-27
SK7112000A3 (en) 2000-10-09
KR100599350B1 (en) 2006-07-12
HUP0100098A2 (en) 2001-07-30
CN1243540C (en) 2006-03-01
JP2001523642A (en) 2001-11-27
CN1285742A (en) 2001-02-28
EE200000290A (en) 2001-06-15
KR20010032099A (en) 2001-04-16
ID24933A (en) 2000-08-31

Similar Documents

Publication Publication Date Title
DE69219378D1 (en) Investment casting process and composition of the model
DE69612185D1 (en) BLEACHING METHOD AND BLENDER COMPOSITION
FI970859A7 (en) Metal treatment composition and process
DE59306638D1 (en) Process for the preparation of 2,2,6,6-tetramethylpiperidine-N-oxyl and derivatives substituted in its 4-position
SI0734260T1 (en) Paroxetine tablets and the process for their preparation
WO1999005096A3 (en) Urokinase inhibitors
DE69826811D1 (en) Compositions for use in the treatment and prevention of hyperuricaemia
CA2258701A1 (en) Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
DE69413051D1 (en) DETERGENT COMPOSITIONS CONTAINING AGENTS FOR PREVENTING THE TURNING OF SILVER
IL145301A0 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
NO982712D0 (en) Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine
NO20001412D0 (en) Compositions and Methods in the Treatment of Respiratory Disorders
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
DE69300062D1 (en) Process for the preparation of N-methoxy derivatives of 4-hydroxy-2,2,6,6-tetramethylpiperidine and 2,2,6,6-tetramethyl-4-piperidone.
NO20002450D0 (en) Compilation of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of Alzheimer's senile dementia
HUP0000756A3 (en) Use of levobupivacaine or ropivacaine for producing pharmaceutical compositions suitable for treating migraine
EP0714890A3 (en) Process and the preparation of 4-amino-2,2,6,6-tetra-methyl piperidine
HU9800396D0 (en) Pharmaceutical composition for treating dementia
HUT74615A (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same
NO20001758D0 (en) Methods and compositions for the treatment of arthritis
HU9800511D0 (en) Process for producing 4-{4-[4-(hydroxy-diphenyl)-1-piperidinyl]-1-hydroxy-butyl}-alpha-alpha-dimethyl-phenyl-acetic.acid and phosphorylized derivatives thereof
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ATE224711T1 (en) FORMULATION FOR THE TREATMENT AND/OR PREVENTION OF DEMENTIA
HUP0001185A3 (en) 1-phenylalkyl-1,2,3,6-tetrahydropyridines, process for producing them and pharmaceutical compositions containing them
HK1028354A (en) Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia